QR Kodea

Effectiveness of Spironolactone in Reducing Osteoporosis and Future Fracture Risk in Middle-Aged and Elderly Hypertensive Patients

Shuaiwei Song,1– 5,* Xintian Cai,1– 5,* Junli Hu,1– 5 Qing Zhu,1– 5 Di Shen,1– 5 Huimin Ma,1– 5 Yingying Zhang,1– 5 Rui Ma,1– 5 Wenbo Yang,1– 5 Jing Hong,1– 5 Delian Zhang,1– 5 Nanfang Li1– 5 1Hypertension Center of People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, 830...

Deskribapen osoa

Gorde:
Egile Nagusiak: Song S, Cai X, Hu J, Zhu Q, Shen D, Ma H, Zhang Y, Ma R, Yang W, Hong J, Zhang D, Li N
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2024-06-01
Saila:Drug Design, Development and Therapy
Gaiak:
hypertensive
spironolactone
aldosterone
osteoporosis
frax score
Sarrera elektronikoa:https://www.dovepress.com/effectiveness-of-spironolactone-in-reducing-osteoporosis-and-future-fr-peer-reviewed-fulltext-article-DDDT
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak